Omish Pharmaceuticals Private Limited

Omish Pharmaceuticals Private Limited - pharma in Delhi, India. Directors, charges & compliance details.
CIN U24233DL2006PTC149726 Incorporated 14 June 2006 ROC Delhi HQ Delhi, India
Struck Off Private Limited Company pharma
Data last updated
Revenue · FY 2023
₹2.41 Lakh
▼ 93% YoY
Net loss · FY 2023
₹59,900
Net margin -24.9%
EBITDA · FY 2023
-₹59,900
EBITDA margin -24.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
20 yrs
Est. 2006
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Omish Pharmaceuticals Private Limited

Data last updated:

Omish Pharmaceuticals Private Limited was a private limited company based in Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 June 2006.

The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2006PTC149726. Its GSTIN is 06AAACO8567D1ZE (Haryana).

The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Meenu Mahajan and Niharika Mahajan.

Its last annual general meeting (AGM) was held on 22 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at 1/7227 – I Shivaji Park Shahdara, Delhi, India – 110032.

As per the financials filed for FY 2023, the company reported a revenue of ₹2.41 Lakh, a decline of 93% compared to the previous year. For the same year it recorded a net loss of ₹59,900 (net margin -24.9%) and EBITDA of -₹59,900 (EBITDA margin -24.9%).

Company details

CIN U24233DL2006PTC149726
Registration Number 149726
Incorporation Date 14 June 2006
ROC Delhi
Listing Status Unlisted
Company Status Struck Off
Date of Last AGM 22 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant

Contact details

Omish Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    1/7227 – I Shivaji Park Shahdara, Delhi, India – 110032
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Omish Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Omish Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Omish Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Omish Pharmaceuticals Private Limited, buy the company report.

Financials of Omish Pharmaceuticals Private Limited

FY 2023 filings available

Omish Pharmaceuticals Private Limited reported revenue of ₹2.41 Lakh (down 93% YoY) for FY 2023.

Revenue · FY 2023
₹2.41 Lakh ▼ 93%
Net loss · FY 2023
₹59,900 margin -24.9%
EBITDA · FY 2023
-₹59,900 margin -24.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 93%
EBITDA CAGR growth
1 year
▼ 223%
3 years · compounded
▼ 115%
5 years · compounded
▼ 58%

Revenue fell 93% in the latest year. EBITDA fell 223% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹59,900
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹59,900
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin-24.9%
Net Profit Margin-24.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Omish Pharmaceuticals Private Limited, buy the company report.

Board of directors of Omish Pharmaceuticals Private Limited

Omish Pharmaceuticals has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Meenu MahajanDirector13 Aug 200818 Years 2 MonthsAs last reported
Niharika MahajanAdditional Director15 Dec 20214 Years 10 MonthsAs last reported

Peer comparison

Omish Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Zen Mineral Chemicals Private Limited₹2.43 Lakh (FY 2019)-91.0%Navi Mumbai, Maharashtra, India
Emblem Pharmaceuticals Private Limited₹2.41 Lakh (FY 2025)-58.0%Delhi, India
Evoluent Pharmaceuticals Private Limited₹2.41 Lakh (FY 2021)-55.0%Palace Guttahalli, Karnataka, India
Omish Pharmaceuticals Private Limitedthis company₹2.41 Lakh (FY 2023)-₹59,900-24.9%-93.0%Delhi, India

To see the full peer comparison of Omish Pharmaceuticals Private Limited, buy the company report.

Auditor

Omish Pharmaceuticals Private Limited is audited by VIPUL KUMAR GOEL & CO for the financial year 2021.

Auditor firmFinancial yearFirm registration number
VIPUL KUMAR GOEL & COFY 2021021325N

Shareholding

The shareholding of Omish Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2018FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Omish Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Omish Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Omish Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
06AAACO8567D1ZEHaryanaActive01 Apr 2021

To see the full GST registrations and return filing status of Omish Pharmaceuticals Private Limited, buy the company report.

Recent activity

Omish Pharmaceuticals Private Limited has 8 board changes on record since 2007: 2 appointments and 6 cessations. The latest: Niharika Mahajan was appointed as Additional Director on 15 Dec 2021.

AGM
Omish Pharmaceuticals Private Limited last Annual general meeting of members was held on 22 Sep 2023 as per latest MCA records.
Filing
Omish Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
Appointed
Niharika Mahajan was appointed as Additional Director.
Ceased
Ashish Gupta ceased to be Director.
Ceased
Anju Bala ceased to be Director.
Ceased
Anju Chamoli ceased to be Director.
Ceased
Ravi Rani ceased to be Director.
Appointed
Meenu Mahajan was appointed as Director.
Ceased
Reena Kushwa ceased to be Director.
Ceased
Vinod Budhiraja ceased to be Director.
Incorporation
14 Jun 2006
Omish Pharmaceuticals Private Limited was registered on 14 Jun 2006 with Roc Delhi & aged 20 years 4 months as per MCA records.

Frequently asked questions

Omish Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Omish Pharmaceuticals was a private limited company based in Delhi, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 14 June 2006 and is registered under CIN U24233DL2006PTC149726. The company has been struck off by the Registrar of Companies and is no longer operational.

Omish Pharmaceuticals had 2 directors:

The CIN (Corporate Identification Number) of Omish Pharmaceuticals is U24233DL2006PTC149726. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Omish Pharmaceuticals is at 17227 – I Shivaji Park Shahdara, Delhi, India – 110032.

Omish Pharmaceuticals was incorporated on 14 June 2006. It is registered with the Registrar of Companies, Delhi.

The latest financial statements of Omish Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 22 September 2023. Year-wise statements from 2015 are in the company report.

The GSTIN of Omish Pharmaceuticals is 06AAACO8567D1ZE, registered in Haryana.

Omish Pharmaceuticals operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.

The peers of Omish Pharmaceuticals by revenue are Zen Mineral Chemicals Private Limited, Emblem Pharmaceuticals Private Limited, Evoluent Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).

Niharika Mahajan was appointed as Additional Director on 15 Dec 2021. Ashish Gupta ceased to be Director on 08 Nov 2021. Anju Bala ceased to be Director on 24 Sep 2013. Omish Pharmaceuticals has 8 board changes on record in total.